Please ensure Javascript is enabled for purposes of website accessibility
Dow development laboratories, llc is a company specialized in topical drug product manufacturing and formulation. We take pride in providing top-notch services for topical formulation design.
Dow development laboratories, llc is a company specialized in topical drug product manufacturing and formulation. We take pride in providing top-notch services for topical formulation design.
A man in a suit gives a presentation at a podium with slides on "Outcomes of the Paraben Free Discussion" displayed on a large screen in a classroom or lecture hall.

Upcoming Events & News

Stay ahead of the curve by gaining in-depth knowledge about Dow Development Laboratories, LLC (DDL) through our participation in various pharmaceutical industry conferences and events.  Join us at upcoming conferences and events to discuss the development of semi-solid and liquid drug products for clinical testing.

News and Upcoming Events

Sateesh Kandavilli, PhD, Joins Dow Development Laboratories as Senior Director, CMC

Dow development laboratories, llc is a company specialized in topical drug product manufacturing and formulation. We take pride in providing top-notch services for topical formulation design.

August 10, 2026

In his new role, Dr. Kandavilli will lead CMC strategy and execution across pharmaceutical development programs, supporting clients from early-stage formulation through commercial manufacturing. Sateesh will oversee CMC regulatory strategy, pharmaceutical development, process optimization, manufacturing readiness, technology transfer, and cross-functional collaboration to accelerate product development and regulatory success.

Dr. Kandavilli brings more than two decades of experience in successfully bringing pharmaceutical products from inception through to commercialization. Throughout his career (including roles at Promius and Bausch Health) he has successfully led multidisciplinary teams in the development of topical, transdermal, injectable, oral, and complex drug products while supporting numerous IND, NDA, ANDA, and global regulatory submissions for multiple products such as CABTREO® (clindamycin phosphate, adapalene, and benzoyl peroxide) topical gel, SERNIVO™ (betamethasone dipropionate) spray and IMPOYZ® (clobetasol propionate) Cream, 0.025%.

As Senior Director, CMC, Dr. Kandavilli will work closely with DDL project teams comprised of formulation scientists, analytical development teams, manufacturing operations, quality assurance, clinical packaging and labeling and project management, to deliver development strategies that support successful product approvals and commercialization for our clients.

Poster for the 10th Anniversary Dermatology Drug Development Summit, November 3–5, 2026, in Boston, MA, listed under industry news and events.

DDL to Exhibit at the 10th Dermatology Drug Development Summit

Dow Development Labs will be exhibiting at the 10th Dermatology Drug Development Summit, taking place November 3-5, 2026 in Boston, MA.

Now in its tenth year, the summit is one of the field’s most focused gatherings, bringing together researchers, clinicians, and industry teams advancing the science and development of dermatological and topical drug products. For a topical-focused CDMO like DDL, it is an ideal opportunity to connect with sponsors working on creams, gels, ointments, and other semisolid and topical programs.

If your team is attending, we welcome the chance to connect and discuss how DDL supports topical drug development from formulation and analytical work through cGMP manufacturing. Visit us on the exhibit floor.

To learn more about the summit, visit the event website.

Dermatology Summit news event on January 10, 2027, at the Hyatt Regency, Embarcadero in San Francisco, CA.

DDL to Sponsor the Dermatology Summit 2027

Dow Development Labs is proud to sponsor the Dermatology Summit 2027, taking place January 10, 2027 at the Hyatt Regency Embarcadero in San Francisco. The summit brings together the entrepreneurs, investors, and industry leaders shaping the future of dermatology, and as a topical-focused CDMO based in Northern California, we’re glad to support it close to home. If your team is attending, we’d welcome the chance to connect.

Dow development's booth showcasing topical drug product method and formulation design at a trade show.

Past Events

  • AAPS 2026 PharmSci 360 Conference Taking Place in New Orleans Oct. 25-28
  • Meet us at the 2026 Contracting & Outsourcing Conference September 24-25 - Visit Dow’s exhibit table #17 at the 25th Annual Contract Pharma Conference and Tabletop Exhibition in New Brunswick, to discuss semi-solid and oral liquid drug product development. This busy conference is an excellent opportunity to meet face to face with vendors of all types, attend sessions for keys to outsourcing success, and network with others in the pharmaceutical and biotech industry.
  • DDL to Exhibit at the 2026 Innovations in Dermatological Sciences Conference at Rutgers University Sept. 22-23.
  • DDL at BIO in June in San Diego - Please reach out to us to schedule a meeting to discuss topical product development – from early formulation development through clinical supplies, packaging, labeling and distribution.
  • Dow Development Labs will be exhibiting at Booth #531 in the Pennsylvania Convention Center. This is a premiere networking conference for the pharmaceutical and biotech industries, giving you the opportunity to discuss your product development needs face to face with a variety of different providers of APIs, instrumentation, equipment and services including drug product development and manufacturing.
  • DDL to Exhibit at the Dermatological Innovation Forum in March
  • DDL will be an Exhibitor at the American Association of Dermatology Conference in March
  • DDL will sponsor the 9th Annual Dermatological Drug Development Summit Nov. 19-20 at the Revere Hotel in Boston. Meet with us to explore your compound as a topical drug product.
  • DDL will be exhibiting Nov 9-12 at the American Association of Pharmaceutical Scientists Annual Meeting. Meet with us in San Antonio to discuss development of topical drug products.
  • Join Us at DDL’s Exhibit Table at the Contract Pharma Contracting and Outsourcing Conference and Tabletop Exhibition
  • DDL to Sponsor and Exhibit at the Innovations in Dermatological Sciences Conference 2025 in New Jersey Sept. 16-17
  • DDL to Exhibit at the Topical Products Conference (TPC) 2025 in Atlanta, GA in June
  • Meet with DDL at the Society for Investigative Dermatology Annual Meeting in May
  • DDL will exhibit at the CPHI Americas Conference May 20-22, Booth #1537. Please join us to discuss your drug product development needs, network with colleagues, and attend presentations such as Market Trends in Pharma, Biotech IPOs, and Clinical Innovation & Technology.
  • Join us at the Dermatology Innovation Forum March 6 at the Orlando Hilton in Florida.  DDL is a sponsor and exhibitor of this unique networking venue where physicians, scientists, investors, inventors and patient advocates can communicate with, learn from, and collaborate with each other on the future of dermatology innovation.
  • Dow Development Labs will be an exhibitor at the Annual American Association of Dermatology in Orlando, FL March 7-9.
  • Meet with us at the 12th Annual Dermatology Summit at the Hyatt Regency in San Francisco on January 12, 2025
  • Discuss topical product development with us at the 8th Annual Dermatological Drug Development Summit Nov 13-14, 2024 in Boston
  • Pharmaceutical Technology publishes results of an interview with DDL’s CMC Manager based on DDL’s experience in understanding how to overcome “Challenges in Clinical Manufacturing for Topical Drugs”
  • Dow Development Labs presented an AAPS webinar “Topical Drug Products: Manufacturing Scale Up and Tech Transfer”, May 29, 2020 12PM EDT